UNIVERSITY OF CALIFORNIA, DAVIS
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1905-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ucdavis.edu
Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Phase 1
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-09-20
- Lead Sponsor
- University of California, Davis
- Registration Number
- NCT00009750
- Locations
- 🇺🇸
University of California Davis Cancer Center, Sacramento, California, United States
Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer
Phase 1
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-09-20
- Lead Sponsor
- University of California, Davis
- Registration Number
- NCT00009763
- Locations
- 🇺🇸
University of California Davis Cancer Center, Sacramento, California, United States
© Copyright 2024. All Rights Reserved by MedPath